Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

Clinical trial NCT00080262 · COMPLETED

Trial details

NCT number: NCT00080262
Sponsor: R-Pharm
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastases

Start date: 2004-02-01
Primary completion: 2006-12-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.